CBS 2019
CBSMD教育中心
中 文

Transcatheter Aortic Valve Replacement

Abstract

Recommended Article

Bioprosthetic valve oversizing is associated with increased risk of valve thrombosis following TAVR Relationship between B-type natriuretic peptide and invasive haemodynamics in patients with severe aortic valve stenosis Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement

Clinical TrialVolume 41, Issue 20, 21 May 2020, Pages 1890–1899

JOURNAL:Eur Heart J. Article Link

Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial

H Thiele, T Kurz et al on behalf of the SOLVE-TAVI Investigators. Keywords: self-expandable vs. balloon-expandable valves; RCT

Full Text PDF